Financial Year |
March 31 2023 |
Monetary Funds |
140,367,486.79 |
Held-for-trading Financial Assets |
834,108,935.08 |
Notes Receivable |
8,387,642.64 |
Accounts Receivable |
396,059,392.59 |
Advances to Suppliers |
75,006,884.54 |
Other Receivables |
88,262,740.37 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
233,205,034.50 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
9,782,027.14 |
Total Current Assets |
1,785,180,143.65 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
96,023,108.46 |
Investment Properties |
-- |
Fixed Assetes |
249,779,450.66 |
Under-construction Projects |
136,039.23 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
289,613,975.57 |
R&D expenses |
12,724,696.60 |
Goodwill |
4,783,848.51 |
Long-Term Deferred and Prepaid Expenses |
12,407,393.73 |
Deferred Income Tax Assets |
24,933,215.77 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
706,288,568.06 |
Total Assets |
2,491,468,711.71 |
Short-Term Loans |
69,600,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
198,762,244.93 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
9,188,777.16 |
Taxes Payable |
21,683,012.03 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
75,356,816.23 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
8,880,460.05 |
Other Current Liabilities |
9,743,439.21 |
Sub-Total of Current Liabilities |
511,187,074.23 |
Long-term Loans |
10,349,450.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
599,011.68 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
37,898,570.86 |
Total Liabilities |
549,085,645.09 |
Paid-In Capital(Or Share Stock) |
724,480,225.00 |
Capital Surplus |
1,570,211,691.95 |
Surplus Reserve |
27,979,944.37 |
LESS:Treasury Stock |
4,860,746.34 |
Undistributed Profits |
-373,496,300.12 |
Minority Stockholder's Interest |
-11,208,868.56 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,953,591,935.18 |
Owner's Equity(Stockholder's Equity) |
1,942,383,066.62 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,491,468,711.71 |